Clinical characteristics of the AML samples
Characteristics . | Number . |
|---|---|
| Gender | |
| Male | 77 |
| Female | 85 |
| Age, median (range), y | 42.3 (15.2-60.8) |
| Age groups | |
| Younger than 35 | 51 |
| 35-50 | 62 |
| 50 and older | 49 |
| FAB | |
| M0 | 4 |
| M1 | 39 |
| M2 | 33 |
| M3 | 13 |
| M4 | 32 |
| M5 | 36 |
| M6 | 2 |
| Unclassified | 3 |
| Cytogenetic risk group | |
| Favorable | 34 |
| inv(16) | 12 |
| t(8;21) | 11 |
| t(15;17) | 11 |
| Intermediate | 111 |
| Unfavorable | 17 |
| WBC count, median (range), 109/L | 29.8 (0.3-263) |
| Blast count, median (range), % | 66 (0-98) |
Characteristics . | Number . |
|---|---|
| Gender | |
| Male | 77 |
| Female | 85 |
| Age, median (range), y | 42.3 (15.2-60.8) |
| Age groups | |
| Younger than 35 | 51 |
| 35-50 | 62 |
| 50 and older | 49 |
| FAB | |
| M0 | 4 |
| M1 | 39 |
| M2 | 33 |
| M3 | 13 |
| M4 | 32 |
| M5 | 36 |
| M6 | 2 |
| Unclassified | 3 |
| Cytogenetic risk group | |
| Favorable | 34 |
| inv(16) | 12 |
| t(8;21) | 11 |
| t(15;17) | 11 |
| Intermediate | 111 |
| Unfavorable | 17 |
| WBC count, median (range), 109/L | 29.8 (0.3-263) |
| Blast count, median (range), % | 66 (0-98) |
FAB indicates French-American-British; WBC, white blood count.